108 results
8-K
EX-10.1
APTO
Aptose Biosciences Inc
1 May 24
Entry into a Material Definitive Agreement
4:30pm
credibility in the funding community;
A commitment to and understanding of the Corporation’s beneficiaries and mission preferably based on experience;
Savvy
424B4
APTO
Aptose Biosciences Inc
26 Jan 24
Prospectus supplement with pricing info
5:30pm
payers, insurers, the medical community and other stakeholders. The degree of market acceptance of our product candidates, if approved for commercial sale … to community property laws where applicable and subject to the information contained in the notes to the table.
Name of Beneficial Owner
Amount
8-K
EX-99.1
0erl01
10 Oct 19
Results of Operations and Financial Condition
7:30am
DEF 14A
2sg 0aihcogw
8 May 19
Definitive proxy
4:31pm
10-Q
l2tuwneunxgp8a1p8
7 May 19
Quarterly report
4:47pm